Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

DocGo (DCGO) Research & Development: 2021-2025

Historic Research & Development for DocGo (DCGO) over the last 5 years, with Q3 2025 value amounting to $3.2 million.

  • DocGo's Research & Development rose 151.46% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year increase of 2408.88%. This contributed to the annual value of $11.6 million for FY2024, which is 672.89% up from last year.
  • Latest data reveals that DocGo reported Research & Development of $3.2 million as of Q3 2025, which was up 151.46% from $3.0 million recorded in Q2 2025.
  • DocGo's 5-year Research & Development high stood at $3.7 million for Q4 2024, and its period low was $569351.0 during Q1 2021.
  • For the 5-year period, DocGo's Research & Development averaged around $2.2 million, with its median value being $2.4 million (2024).
  • Its Research & Development has fluctuated over the past 5 years, first soared by 13561.23% in 2023, then tumbled by 797.82% in 2024.
  • DocGo's Research & Development (Quarter) stood at $1.3 million in 2021, then grew by 28.54% to $1.7 million in 2022, then surged by 85.03% to $3.2 million in 2023, then grew by 15.7% to $3.7 million in 2024, then dropped by 13.35% to $3.2 million in 2025.
  • Its last three reported values are $3.2 million in Q3 2025, $3.0 million for Q2 2025, and $3.6 million during Q1 2025.